KIFFIK is building the access layer to continuous human biology. Our K-EXP platform enables real-time, tissue-level molecular insight through longitudinal access to interstitial fluid, moving diagnostics and drug development beyond episodic testing. We partner with pharmaceutical, diagnostics, and healthcare leaders to accelerate drug discovery, improve clinical trial efficiency, enable next-generation companion diagnostics, and generate real-world evidence that reflects biology as it actually behaves. KIFFIK is infrastructure, not a single test or device. One platform, multiple indications, designed to scale across partners and pipelines. We work with teams who believe the future of medicine depends on continuous access to biology, and who are ready to build what comes next.